secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001558370-24-002613
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Virios shareholders approve reverse stock split at special meeting
------------------------------------------------------------------

- Special meeting held March 1, 2024; quorum 64.58% of shares outstanding.
- Proposal 1 (reverse stock split) approved with 7,553,703 For vs 4,697,955 Against.
- Proposal 2 (adjournment to solicit proxies) approved with 7,778,383 For vs 4,484,974 Against.
- No broker non-votes; both proposals passed by required vote.
- Reverse split effective date and ratio not disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024002613/0001558370-24-002613-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024002613/tmb-20240301x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-002613

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer